Kidney disease

New drugs

ACCEL-Sevelamer

Medical ingredient:

Sevelamer Carbonate

Indication:

ACCEL-Sevelamer is used for the control of high phosphorus levels in patients with end stage kidney disease undergoing dialysis (whether hemodialysis or peritoneal dialysis).

For more information, see the Regulatory Decision Summary.

New generic drugs

Health Canada approved one new generic drug for kidney disease.

Risk communications

Health Canada released one risk communication on kidney disease.

Page details

Date modified: